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ODC responses to hypoxia were examined by separating 6-dold pups from their dams and placing them in a covered 6-L plastic pan kept at 37°C in an incubation bath. The container was then ventilated for 1, 2, or 4 h with warmed, humidified room air (controls) or warmed humidified 7% oxygen + 93% nitrogen at a rate of 15 L/min (30) . Under these conditions, the Po2 of source and exhaust gases were equal. Because studies in our laboratory have demonstrated that even a short-term separation of developing rat pups from their dams evokes a decrease of ODC activity in most tissues (3 I), simultaneous measurements were conducted in animals that were left with their dams and not gassed. The data was then compared with that obtained in littermates that went through the separation procedure and were exposed to room air in the apparatus.
Synthesis of proteins in viva was evaluated by measuring incorporation of [3H]leucine into proteins as described in detail in an earlier publication (32) .
ODC activity. Whole lung was homogenized (Polytron) in 19 volumes of chilled 10 mM Tris buffer (pH 7.2), centrifuged at 26 000 x g for 20 min, and ODC activity measured in the supernatant by a modification of the method of Russell and Snyder (33) . The incubation medium contained 0.9 mL of supernatant, and final concentrations of 4.8 pM L-[1-I4C]ornithine, 1.8 mM DTT, and 50 pM pyridoxal-5'-phosphate in a total volume of I mL. Incubation vials were capped with serum stoppers into which center wells containing paper filter wicks had been fitted. After a 30-min incubation at 37°C 0.5 mL of 10% trichloroacetic acid was added to stop the reaction and then 0.2 mL of hyamine hydroxide was added to the paper wicks to trap the liberated I4CO2 during a second 30-min incubation. Center wells were placed in scintillation fluid and counted for radioactivity. ODC activity is expressed as nmol I4CO2 evolved/ g of lung/h.
Determination of enzyme kinetics of ODC.
Four h after i.c. administration of 1.5 pg BE/g brain $ or saline to 6-d-old rats, lung ODC activity was measured (in triplicate) in pooled supernatants from each treatment group, using a range of L-ornithine concentrations from 2.43 to 155.2 pM as previously reported by us and other investigators (34) (35) (36) . ODC activity at the different concentrations of ornithine was then analyzed by linear regression using a double reciprocal plot to obtain the Km and V, , , for each treatment. To ensure that the measured enzyme activity did not result from nonspecific decarboxylation (which might be found when high concentrations of ornithine are used), lung ODC activity was also determined in a different group of rats given a maximally effective dose of a-difluoromethylornithine, a specific, potent, and irreversible inhibitor of ODC activity (37) . The residual enzyme activity after a-difluoromethylornithine treatment was then subtracted from the total ODC values at each ornithine concentration. Nonspecific activity ranged from 5 to 20% of the total ODC values.
Corticosterone concentrations. Blood was collected into polystyrene tubes, allowed to clot at 4°C for 10 min, and then centrifuged at 1000 x g for 10 min. Serum was stored at -40°C until assayed. Corticosterone was assayed by RIA after extraction from serum with ethylacetate using antiserum and corticosterone standard supplied by Radioassay Systems Laboratories, Inc. Statistics. Data are reported as means + SEM. Statistical analysis used two-or three-way analysis of variance as indicated, followed post hoc by either Duncan's multiple range test or t test (two-tailed, unpaired) where appropriate. Significance was tested at p < 0.05.
RESULTS
Effect of BE on lung ODC activity in 6-d-old rats. Administration of BE i.c. produced a dose-related decrease in lung ODC activity (Fig. I) . Enzyme activity in animals given the highest dose (1.5 pg/g brain wt) was reduced to approximately 20% of control values.
Because tissue ODC responses to i.c. BE could result from direct peripheral actions of this neuropeptide after its leakage into systemic blood, similar studies were conducted in a different group of rats treated S.C. with BE. Peripheral administration of 0.5 or 1 pg of BE, amounts equivalent to those given centrally (0.75 or 1.5 on a pg/g brain wt basis, respectively), or even 10 pg of BE had no overall significant effect on ODC activity (data not shown).
Mechanisms underlying effect of BE on lung ODC activity in 6-d-old rats. To determine whether the effect of CNS BE on lung ODC activity is mediated by classical opioid receptors, similar studies were conducted in animals treated with 3 pg of naloxone/ g brain wt (a dose shown to block brain opioid receptors in the rat) (14, 38) . Coadministration of naloxone with BE i.c. reversed the decreases in ODC activity normally seen in rat pups given BE (Fig. 2) . Naloxone alone did not significantly alter basal lung ODC levels.
Kinetic studies were undertaken to establish whether BE actions on lung ODC activity reflect changes in enzyme affinity or V,,,. As shown in Figure 3 , BE treatment evoked a dramatic reduction in V, , , (from 10.53 in controls to 3.13 nmoljglh in BE-treated animals) without a significant change in Km.
Glucocorticoids have been shown to delay the pattern of cellular development in rat lung, in part, by acting on ODC activity (26) . Thus, it is possible that the lung ODC responses we observed in rat pups given BE i.c. reflect actions of this neuropeptide on plasma corticosterone levels. As shown in Figure 4 , plasma corticosterone was 25 + 3 ng/mL 1 h after receiving BE, a value approximately five times higher than that seen in control animals. As was the case for ODC. the corticosterone effect was totally reversed by naltrexone (a long-lasting opioid antagonist) (Fig. 4) .
Central administration of BE has been reported to depress respiration in dogs (39) . Similarly, in human studies exogenous opiate alkaloids inhibit respiration as well as ventilatory responses to hypoxia and hypercapnia (40) . Thus, it is conceivable that the decreases in lung ODC activity that we have observed in BE-treated pups may be related to a decline in cell metabolism usually associated with ventilatory depression. One way to investigate this possibility is by assessing the effect of hypoxia on lung ODC activity. Studies of neonatal hypoxia require the dams to be absent during the gassing period as they become extremely agitated under the low 0 2 conditions. Because even short-term interruption of mother-pup interactions are known to decrease ODC levels in most tissues (31), we also measured enzyme activity in rat pups that were left with their dams for the duration of the experiment. As shown in Table 1 , exposure to 7% 0, for 1, 2, or 4 h markedly increased lung ODC activity, whether compared with that of separated animals gassed with room air or that of control rats (left with their mothers).
Metenkephalin has also been shown to cause respiratory depression (4 1,42) . Therefore, to further investigate the potential role of hypoxia on the ODC effect of BE, we measured lung ODC activity in rats given metenkephalin i.c. Administration of doses of metenkephalin as high as 1.65 pglg brain wt (10 times the highest dose of BE used in our studies, on a molecular weight basis) had no overall significant effect on enzyme activity (data not shown).
The possibility that the decreases in ODC activity reflect nonspecific toxic responses to BE was investigated through measurements of protein synthesis, as assessed by [3H]leucine incorporation into trichloroacetic-precipitable material. Rats were injected i.c. with BE followed 1 h later by a s.c. injection of [3H] leucine (0.5 pCi/g body wt), and protein synthesis was determined 20, 40, and 80 min after the second injection. BE treatment did not alter the percentage of [3H]leucine incorporation into proteins as analyzed by two-way analysis of variance (control groups = 27.7 + 0.6, 34.4 2 1.3, and 39.5 2 0.5; BE groups = 24.9 + 1.1, 33.0 + 1.7, and 45.3 + 1.3 at 20, 40 , and 80 min, respectively; data represent the means k SEM of values from nine to 19 animals/group/time point).
Effect of BE on lung ODC activity in rats of dzfferent ages. In agreement with previous reports, control animals showed a peak in basal lung ODC activity at 6 d of age followed by a decrease to very low values at postnatal d 14 and a substantial late rise in enzyme activity from postnatal d 18-30 (26, 29) (Fig. 5) . BE administration inhibited tissue ODC activity during the first 2 wk of age, but had no effect on 18-or 30-d-old animals.
DISCUSSION
The results from these studies demonstrate that ODC activity in the neonatal rat lung is highly sensitive to changes in CNS BE levels. We found that i.c. doses of BE as low as 0.5 pg/g brain wt significantly decreased ODC activity. Subcutaneous administration of even 10 times the highest amount of BE given i.c. did not alter lung ODC activity, indicating that the effect results indirectly from CNS actions of BE. Centrally mediated effects of CNS BE on other peripheral tissues have been recently reported by our laboratory (14, 43, 44) .
Coadministration of naloxone with BE i.c. prevented the decreases in lung ODC activity evoked by BE alone, indicating an opioid-receptor-mediated phenomenon. This finding contrasts with our previous observations showing that the same dose of naloxone i.c. did not block the inhibitory effect of BE on liver ODC activity (14) . Concurrent determinations of ODC activity in the lung and liver confirmed these tissue differences.
The postnatal rat lung progresses through three distinct devel- 4-1 3), and terminal differentiation (postnatal d 14-2 1) (1 5). The opioid effect was clearly seen on postnatal d 2-14 but was no longer apparent by postnatal d 18. The insensitivity to BE during the terminal differentiation period could not be explained by its typically low basal ODC levels inasmuch as 30-d-old pups (whose basal lung ODC activity is very high) also did not respond to BE, even when twice the dose of BE administered to younger pups was used.
Enzyme kinetic studies eliminated the possible participation of a posttranslational inhibitor, inasmuch as no significant changes in Km were obtained. This would be expected if changes in enzyme afinity for ornithine had occurred (35, 45) . In contrast, ODC V,,, in BE-treated rats was approximately 70% lower than control values, a decrease similar to that of ODC activity. It is then clear that BE reduces lung ODC activity by inhibiting its de novo synthesis rather than by a posttranslational mechanism.
BE has been reported to cause respiratory depression in dogs (39) , suggesting that the decreases in lung ODC activity we have observed in BE-treated rat pups may result from actions of this neuropeptide on ventilation. The following observations, however, make this possibility unlikely. l ) We found that 6-d-old rats exposed to hypoxia (7% 0 2 for 1 to 4 h) actually showed profound increases in lung ODC activity. 2) Metenkephalin, which has also been shown to cause respiratory depression (41, 42) , did not alter lung ODC activity even when five times the highest dose of BE used in these studies was administered.
3) The respiratory actions of BE were naloxone reversible (39) . Accordingly, this opioid antagonist should also block the ODC effect in all tissues if both phenomena are causally related. Although naloxone reversed BE's action on lung ODC (in this study), it did not prevent the effect on liver ODC (14). 4) Furthermore, rat pups given 0.15 pg BE/g brain wt, a dose that did not significantly alter rectal temperature (an index of metabolic activity), showed significant decreases in brain and liver DNA synthesis (44). 5 ) Finally, the ODC effect could not be attributed to a generalized toxic response as protein synthesis was not altered.
At first, BE's inhibition of ODC activity appears to contradict the postulated acceleration of lung maturation by endogenous opioids, but this might not be the case. Although pulmonary function in premature offspring born to opiate-addicted mothers is similar to that found in full-term offspring born to normal mothers (4-7), body weights are markedly subnormal (1). Glucocorticoids are also known to evoke dichotomous developmental effects. For example, dexamethasone accelerates the development of lung function by enhancing surfactant synthesis (1 9), but simultaneously slows down proliferation of lung cells as indicated by reduced ODC activity and DNA/lung ratios (26, 46) . In fact, because we found increased plasma corticosterone concentrations after BE administration, it is possible that CNS BE may influence lung maturation through an indirect action on glucocorticoids/stress mechanisms.
Because changes in ODC levels during early postnatal life are indicative of perturbations in cell development, the results from these studies suggest that activation of endogenous CNS BE systems may have a significant impact on lung maturation. Indeed, results from recent studies conducted in our laboratory show that i.c. administration of doses of BE that significantly reduce ODC activity also profoundly decrease lung DNA synthesis (unpublished experiments). Because changes in DNA biosynthetic rates reflect alterations in cell replication, increases in CNS BE levels during early postnatal life could retard lung growth. It can be speculated that, in a manner similar to that of glucocorticoids, the natural release of BE at birth (9, 10, 12) may favor critical events necessary for early adaptation to extrauterine life (such as surfactant production) by restricting the amount of cellular energy directed toward growth-related processes, including ODC activity and DNA synthesis.
